Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / CD Molecules

Recombinant Human CD265/TNFRSF11A Protein, N-His

Catalog #:   YHJ91701 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q9Y6Q6
Protein length: Tyr76-Pro317
Overview

Catalog No.

YHJ91701

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Tyr76-Pro317

Predicted molecular weight

28.41 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q9Y6Q6

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Osteoclast differentiation factor receptor, Receptor activator of NF-KB, TNFRSF11A, ODFR, Tumor necrosis factor receptor superfamily member 11A, CD265, RANK

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human CD265/TNFRSF11A protein
References

[Clinical and genetic characteristics of osteopetrosis in children]., PMID:40462430

Duplications within exon 1 of TNFRSF11A encoding receptor activator of nuclear factor-kappa B (RANK) are associated with tendon avulsion., PMID:40222603

The Expression Profile of the RANK/RANKL/OPG Pathway in Breast Cancer Stem Cells Isolated From Breast Cancer Cell Lines., PMID:40159409

RANK/RANKL Signaling Pathway in Breast Development and Cancer., PMID:39821032

Causal effects of the RANK-RANKL-OPG system and scoliosis: A bidirectional 2-sample Mendelian randomization study., PMID:39686424

RANKL regulates differentially breast cancer stem cell properties through its RANK and LGR4 receptors., PMID:39662745

The Effect of Osteoprotegerin (OPG)/Receptor Activator of Nuclear Factor-κB Ligand (RANKL)/Receptor Activator of Nuclear Factor-κB (RANK) on Aortic Valve Calcified., PMID:39537225

RANK-RANKL-OPG Axis in MASLD: Current Evidence Linking Bone and Liver Diseases and Future Perspectives., PMID:39273141

RANK in cancer-associated fibroblasts: A valuable prognostic determinant for metastasis in early-stage breast cancer patients., PMID:39240628

B-cell intrinsic RANK signaling cooperates with TCL1 to induce lineage-dependent B-cell transformation., PMID:39198400

α-IRAK-4 Suppresses the Activation of RANK/RANKL Pathway on Macrophages Exposed to Endodontic Microorganisms., PMID:39126003

RANKL/RANK signaling recruits Tregs via the CCL20-CCR6 pathway and promotes stemness and metastasis in colorectal cancer., PMID:38902257

Correlation of RANK and RANKL with mammographic density in primary breast cancer patients., PMID:38836929

Elevated tissue expression of RANKL and RANK is associated with poorer survival rates in pancreatic cancer patients., PMID:38230588

Co-targeting RANK pathway treats and prevents acquired resistance to CDK4/6 inhibitors in luminal breast cancer., PMID:37451269

Denosumab Attenuates Glucolipotoxicity-Induced β-Cell Dysfunction and Apoptosis by Attenuating RANK/RANKL Signals., PMID:37373436

CRISPR screens identify novel regulators of cFLIP dependency and ligand-independent, TRAIL-R1-mediated cell death., PMID:36801923

Early identification of a 12-bp tandem duplication in TNFRSF11A encoding receptor activator of nuclear factor-kappa B (RANK): Clinical characterization and response to bisphosphonate therapy., PMID:36740137

ADR3, a next generation i-body to human RANKL, inhibits osteoclast formation and bone resorption., PMID:36634847

The RANK/RANKL/OPG system and tumor bone metastasis: Potential mechanisms and therapeutic strategies., PMID:36589815

Assessment of RANK/RANK-L prevalence and clinical significance in NSCLC European Thoracic Oncology Platform Lungscape cohort and SPLENDOUR randomized clinical trial., PMID:36535121

Familial Paget's disease of bone with ocular manifestations and a novel TNFRSF11A duplication variant (72dup27)., PMID:36520195

RANKL Impairs the TLR4 Pathway by Increasing TRAF6 and RANK Interaction in Macrophages., PMID:35463988

Association Between Serum Selenium Concentration and OPG/RANKL/RANK Axis in Patients with Arterial Hypertension., PMID:35412194

The relationship between chemerin, bone metabolism, the RANKL/RANK/OPG system, and bone mineral density in girls with anorexia nervosa., PMID:35119086

Molecular Mechanisms Leading from Periodontal Disease to Cancer., PMID:35055157

Vertebral osteomyelitis is characterised by increased RANK/OPG and RANKL/OPG expression ratios in vertebral bodies and intervertebral discs., PMID:34846723

The Role of Cannabinoids in Bone Metabolism: A New Perspective for Bone Disorders., PMID:34830256

RANK-C Expression Sensitizes ER-Negative, EGFR-Positive Breast Cancer Cells to EGFR-Tyrosine Kinase Inhibitors (TKIs)., PMID:34828291

The RANKL/RANK system in female reproductive organ tumors: A preclinical and clinical overview., PMID:34435475

The Relationship between Serum and Gene Expression Levels of RANK, RANKL and Osteoprotegerin Inflammatory Pathway with Unstable Angina: A Case-control Study., PMID:34418901

Genetic variations in tumor ecrosis factor related apoptosis-inducing ligand receptor-1 (TRAIL-R1) gene and the susceptibility to b-cell non-hodgkin lymphoma (B-NHL) in Egypt., PMID:34275891

A novel mutation in TNFRSF11A gene causes pediatric osteopetrosis: case report., PMID:34049530

Receptor Activator of NF Kappa B (RANK) Expression Indicates Favorable Prognosis in Patients with Muscle-invasive Bladder Cancer., PMID:33962883

RANK promotes colorectal cancer migration and invasion by activating the Ca2+-calcineurin/NFATC1-ACP5 axis., PMID:33795653

RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer., PMID:33785053

OPG/RANKL/RANK gene methylation among alcohol-induced femoral head necrosis in northern Chinese men., PMID:33773583

Immunoexpression of RANK, RANKL and OPG in sporadic odontogenic keratocysts and their potential association with recurrence., PMID:33768738

Insertion Mutation in Tnfrsf11a Causes a Paget's Disease-Like Phenotype in Heterozygous Mice and Osteopetrosis in Homozygous Mice., PMID:33724536

Human apoptosis antibody array-membranes studying the apoptotic effect of marine bacterial exopolysaccharides in HepG2 cells., PMID:33723130

Bone anti-resorptive effects of coumarins on RANKL downstream cellular signaling: a systematic review of the literature., PMID:33556550

RANK Signaling in the Differentiation and Regeneration of Thymic Epithelial Cells., PMID:33552088

Expanding the phenotypic spectrum of TNFRSF11A-associated dysosteosclerosis: a case with intracranial extramedullary hematopoiesis., PMID:33402699

Association of Polymorphisms in RANK and RANKL Genes with Osteopenia in Arab Postmenopausal Women., PMID:33376557

TRAILR1 (rs20576) and GRIA3 (rs12557782) are not associated with interferon-β response in multiple sclerosis patients., PMID:33269432

The Non-Bone-Related Role of RANK/RANKL Signaling in Cancer., PMID:33119864

Structure of a DNA G-Quadruplex Related to Osteoporosis with a G-A Bulge Forming a Pseudo-loop., PMID:33096904

Pathological RANK signaling in B cells drives autoimmunity and chronic lymphocytic leukemia., PMID:33075129

The third case of TNFRSF11A-associated dysosteosclerosis with a mutation producing elongating proteins., PMID:33037392

Association of a single nucleotide polymorphism of RANK gene with blood pressure in Spanish women., PMID:33019425

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human CD265/TNFRSF11A Protein, N-His [YHJ91701]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only